Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
“…several other cancers are related to HPV, including 95 percent of anal cancer, 60 percent of oropharyngeal, 65 percent of vaginal cancer, 50 percent of vulvar cancer and 35 percent of penileContinue reading
Two doses of nivolumab given about 1 month prior to surgery are well tolerated and reduces tumor size in about half of patients with squamous cell head and neck cancer If you have been diagnosed with headContinue reading
“PDT provides a surgical oncologic modality for potentially curative treatment of early stage oral cavity and laryngeal malignancies with minimal side effects, absence of systemic toxicity, preservationContinue reading
Pooled analysis of four retrospective studies showed no significant difference in nodal recurrence in node-negative nasopharyngeal cancer, whether in-field or out-of-field recurrence. There was also noContinue reading
e “An analysis of Medicare data for more than 1,800 head/neck cancer patients suggests that jaw complications following radiation treatment may be more common than recognized” OsteonecrosisContinue reading
“Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the head and neck, and recurrence is an important prognostic factor in patients with OSCC. Dear Cancer Coach, I have oral squamousContinue reading
“A retrospective review of patients with laryngeal cancer using SEER-Medicare data demonstrated that chemoradiation was 4-fold more likely to be used in patients with advanced laryngeal cancer; however,Continue reading